Page 12 - Sisk News August 2017

A focus on Life Sciences
Building on our achievements within the Life Sciences sector - which has seen over £1.8 billion worth of facilities delivered to global clients such as Johnson & Johnson, P zer and Glaxo Smith Kline since 2000 - the business has identi ed an exciting opportunity for growth and expansion across Europe.
The experience and skills gained by
our teams in the delivery of complex
life science facilities in Ireland has enabled us to be able to bring a unique construction offering to the European
market, in the delivery of these most complex facilities.
Form of contract, client selection and location of works is key to successful expansion into new areas. Appreciating
this, our initial foray into the market has seen us operating as a management contractor for our key client Johnson & Johnson and their subsidiary companies.
We currently work for brands within
the sector’s top 10 and long-standing relationships have matured based on a culture of rst class safety and delivery performance.
There are over 60 in-house commissioning and MEP engineers, fully-integrated with multi-disciplinary specialist skills.
Life Sciences delivery... What it means at Sisk
Our Life Sciences business is split into four main types of work, as shown below.
Sisk has proudly delivered many of
the world-leading and pioneering Pharmaceutical / BioTech and MedTech facilities across the UK, Ireland and Europe.
Frank Quirk is the Regional Managing Director, supported by Tom Wall, Regional Director. Mark Brophy and Joe O’Sullivan undertake the roles of General Manager across Europe and Ireland respectively.
Life Sciences
Pharma
Biotech
Medical Devices
Consumer Products
Biomedicines for conditions including Rheumotoid Arthritis and Psiorisos Manufacturing and packaging
Manufacturing facility
for titanium-cast arti cial replacement joints
Items including shampoo, talcum powder, plasters, creams and cotton buds
Tablets, creams and injectable doses Manufacturing and packaging
Recent projects include:
Janssen Geel, Belgium
Retro t of Active Pharmaceutical Ingredient manufacturing facility.
Janssen, Beerse, Belgium
Construction of new build Cat 2 lab facility which is required to bring all the labs on the agship Janssen Campus under one roof, meeting with regulatory requirements.
Janssen, Leiden, The Netherlands
Construct and commission a large scale vaccine facility within an existing fallow space of the live production facility. This facility will allow Janssen
to quickly bring an antiviral product to the market following clinical trials.
Janssen CILAG, Switzerland
Providing a management function on the technical building scheme, we were asked by the client to join the team and work with the current contractor to our systems of work.
12 Sisk News | August 2017